How Does Morphosys Ag (MOR) Stock Rank on Wall Street Monday?

Wall Street is positive on Morphosys Ag (MOR). On average, analysts give MOR a Buy rating. The average price target is $11.362, which means analysts expect the stock to rise by 130.47% over the next twelve months. That average ranking earns MOR an Analyst Rating of 33, which is better than 33% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating MOR a Buy today. Find out what this means to you and get the rest of the rankings on MOR!

See Full MOR Report

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers. InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With Morphosys Ag Stock Today?

Morphosys Ag (MOR) stock is up 5.67% while the S&P 500 is down -0.08% as of 12:16 PM on Monday, Nov 27. MOR has gained $0.26 from the previous closing price of $4.67 on volume of 756,770 shares. Over the past year the S&P 500 is up 14.93% while MOR has gained 22.94%. MOR earned $0.73 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 6.73. Click Here to get the full Stock Report for Morphosys Ag stock.